Expert Review of Anti-Infective Therapy

Papers
(The H4-Index of Expert Review of Anti-Infective Therapy is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies182
Antimicrobial resistance in low- and middle-income countries: current status and future directions118
Calycosin: a Review of its Pharmacological Effects and Application Prospects74
Current and emerging strategies to combat antimalarial resistance64
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae55
CAR-T cell therapy and infection: a review53
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis51
Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management50
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials49
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal44
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications42
Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities39
Bacterial death from treatment with fluoroquinolones and other lethal stressors37
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies37
Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-235
Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations33
Addressing antimicrobial resistance in Nigerian hospitals: exploring physicians prescribing behavior, knowledge, and perception of antimicrobial resistance and stewardship programs33
A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications33
Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy31
Bacteria and fungi as major bio-sources to fabricate silver nanoparticles with antibacterial activities31
Dengue vaccine: an update30
A review on favipiravir: the properties, function, and usefulness to treat COVID-1930
Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies28
RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study28
Therapeutic strategies to address monkeypox27
Antibiotic consumption among hospitalized neonates and children in Punjab province, Pakistan27
Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis27
0.037229061126709